You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
AstraZeneca
McKinsey
Colorcon
Johnson and Johnson

Last Updated: January 21, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for HSK3486

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug HSK3486?

HSK3486 is an investigational drug.

There have been 23 clinical trials for HSK3486. The most recent clinical trial was a Phase 2 trial, which was initiated on November 20th 2020.

The most common disease conditions in clinical trials are Renal Insufficiency, Liver Diseases, and Renal Insufficiency, Chronic. The leading clinical trial sponsors are Sichuan Haisco Pharmaceutical Group Co., Ltd., Haisco Pharmaceutical Group Co., Ltd., and First Hospital of Jilin University.

There is one US patent protecting this investigational drug and twenty international patents.

Recent Clinical Trials for HSK3486
TitleSponsorPhase
A Clinical Study Evaluating Sedation of Intravenous Administration of HSK3486 in ICU Patients Undergoing Long-Term Mechanical VentilationHaisco Pharmaceutical Group Co., Ltd.Phase 2
A Study to Evaluate the Efficacy and Safety of HSK3486 in the Induction of General AnesthesiaSichuan Haisco Pharmaceutical Group Co., Ltd.Phase 3
A Study Evaluating Sedation of Intravenous Administration of HSK3486 Injectable Emulsion in ICU Patients Undergoing Mechanical VentilationHaisco Pharmaceutical Group Co., Ltd.Phase 3

See all HSK3486 clinical trials

Clinical Trial Summary for HSK3486

Top disease conditions for HSK3486
Top clinical trial sponsors for HSK3486

See all HSK3486 clinical trials

International Patents for HSK3486

Drugname Country Document Number Estimated Expiration Related US Patent
HSK3486 Australia AU2014264103 2033-05-09   Start Trial
HSK3486 Brazil BR112015028212 2033-05-09   Start Trial
HSK3486 Canada CA2911845 2033-05-09   Start Trial
HSK3486 China CN104507899 2033-05-09   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
AstraZeneca
McKinsey
Colorcon
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.